GSK and Online Communities Create Unique Alliance to Stimulate Open Source Drug Discovery for Malaria

GSK becomes first company to freely share chemical structures on 13,500 molecules from its compound library

Alliances formed with leading scientific research communities from private industry and public-domain data provider

May 19, 2010/Burlingame, CA/ GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the US-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.

Beyond Brexit and EU Falsified Medicine Directive

SMi Group Reports: (2016.11.16, London, UK): Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.

With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? SMi’s Parallel Trade conference will be returning to London next February 6th-7th, for its 11th year, to discuss short term and long term concerns of pharma manufacturers, regulators and parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges.

Health authorities, associations and academic sectors in the GCC to collaborate in the advancement of pharmacy practice in the region

Dubai, 16 August 2015:

The shift from product to patient-centered practice in pharmacy is said to be a leading trend in the globe nowadays. The GCC region, believed by some experts to witness rapid developments in its pharmacy practice and education, is among those who are moving towards this trend.

Dr. Lamia Yahya, Clinical Pharmacist at Corniche Hospital in the UAE, believes that the pharmacy practice in the region is booming and is an actively growing profession. "It had moved away from the classic role of just ‘handing in' the medication to the patient, to more orientation towards patient care," she adds. However, some expert suggests that the entire region should place a great emphasis to effectively further advance the profession. An expert from Qatar, Dr. Ahmed Nadir Kheir, Associate Professor and Continuing Professional Pharmacy Development (CPPD) Coordinator for Qatar University, shares that one of the most important factors and tools of change is the advancement in pharmacy education and the emergence of accreditation initiatives, which target quality in health care.

QUALITY COMPLIANCE - A WORKSHOP BY UBM

Chinmoy Roy, an internationally recognized subject matter expert in CSV, CAPA, CFR 21 Part 11, Annex 11, Data Integrity and manufacturing process automation systems will be conducting a workshop at the Proactive Quality Compliance - A Workshop by UBM India, this March!

Rent-a-Business-Development-Manager

Farmavita.Net is the established European network for licensing of pharmaceutical products. Currently there is few thousand registered members e.g several hundred pharmaceutical companies which are using our network for out-licensing and in-licensing of pharmaceutical products.

Finding of contract manufacturing or licensing clients in Europe is not an easy job. It usually takes many business proposals and several months of negotiations before one contract is closed. However, good is that the most of the contracts are valid for 5 or more years.